124 related articles for article (PubMed ID: 25803094)
21. Pharmacokinetics and disposition of L-692,429. A novel nonpeptidyl growth hormone secretagogue in preclinical species.
Leung KH; Cohn DA; Miller RR; Doss GA; Stearns RA; Simpson RE; Feeney WP; Chiu SH
Drug Metab Dispos; 1996 Jul; 24(7):753-60. PubMed ID: 8818572
[TBL] [Abstract][Full Text] [Related]
22. Temporal association as a prerequisite factor of valsartan-induced lithium toxicity.
Lazarczyk MJ; Giannakopoulos P
Bipolar Disord; 2014 Sep; 16(6):662-6. PubMed ID: 24372930
[TBL] [Abstract][Full Text] [Related]
23. Application of an ultra-performance liquid chromatography method with tandem mass spectrometry to pharmacokinetics, tissue distribution and excretion in the study of DAT-230, a novel tubulin-binding agent candidate, in rats.
Tang J; Zhang C; Sun J; Zhao L; Zhang W; Liu Z; Sun L; Chen X
J Pharm Biomed Anal; 2015 Jun; 110():49-57. PubMed ID: 25800882
[TBL] [Abstract][Full Text] [Related]
24. [Obsolete emergency biology. The confluence of critical care analysis and near patient testing].
Bergkuist C; Liffman S
Ann Biol Clin (Paris); 1998; 56(6):749-50. PubMed ID: 9853039
[No Abstract] [Full Text] [Related]
25. Effects of lithium and valproate on hippocampus citrate synthase activity in an animal model of mania.
Corrêa C; Amboni G; Assis LC; Martins MR; Kapczinski F; Streck EL; Quevedo J
Prog Neuropsychopharmacol Biol Psychiatry; 2007 May; 31(4):887-91. PubMed ID: 17367908
[TBL] [Abstract][Full Text] [Related]
26. Kinetics and disposition of hexarelin, a peptidic growth hormone secretagogue, in rats.
Roumi M; Marleau S; du Souich P; Maggi T; Deghenghi R; Ong H
Drug Metab Dispos; 2000 Jan; 28(1):44-50. PubMed ID: 10611139
[TBL] [Abstract][Full Text] [Related]
27. Altered electrolyte handling of the choroid plexus in rats with glycerol-induced acute renal failure.
Ishikawa A; Kono K; Sakae R; Aiba T; Kawasaki H; Kurosaki Y
Biopharm Drug Dispos; 2010 Nov; 31(8-9):455-63. PubMed ID: 20848389
[TBL] [Abstract][Full Text] [Related]
28. Diversion or prevention of biliary outflow from the liver diminishes the renal uptake of injected inorganic mercury.
Zalups RK; Barfuss DW
Drug Metab Dispos; 1996 Apr; 24(4):480-6. PubMed ID: 8801064
[TBL] [Abstract][Full Text] [Related]
29. Influence of curcumin on cyclosporin-induced reduction of biliary bilirubin and cholesterol excretion and on biliary excretion of cyclosporin and its metabolites.
Deters M; Siegers C; Hänsel W; Schneider KP; Hennighausen G
Planta Med; 2000 Jun; 66(5):429-34. PubMed ID: 10909262
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics and toxic effects of lithium chloride after intravenous adminstration in conscious horses.
Hatfield CL; McDonell WN; Lemke KA; Black WD
Am J Vet Res; 2001 Sep; 62(9):1387-92. PubMed ID: 11560265
[TBL] [Abstract][Full Text] [Related]
31. Lithium spectroscopic imaging of rat brain at therapeutic doses.
Ramaprasad S
Magn Reson Imaging; 2004 Jun; 22(5):727-34. PubMed ID: 15172068
[TBL] [Abstract][Full Text] [Related]
32. The association of the effect of lithium in the maintenance treatment of bipolar disorder with lithium plasma levels: a post hoc analysis of a double-blind study comparing switching to lithium or placebo in patients who responded to quetiapine (Trial 144).
Nolen WA; Weisler RH
Bipolar Disord; 2013 Feb; 15(1):100-9. PubMed ID: 23228201
[TBL] [Abstract][Full Text] [Related]
33. Identification of glucuronidation and biliary excretion as the main mechanisms for gossypol clearance: in vivo and in vitro evidence.
Liu H; Sun H; Lu D; Zhang Y; Zhang X; Ma Z; Wu B
Xenobiotica; 2014 Aug; 44(8):696-707. PubMed ID: 24555821
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics of intravenous lithium chloride and assessment of agreement between two methods of lithium concentration measurement in the horse.
Martin LM; Bukoski AD; Whelchel DD; Evans TJ; Wiedmeyer CE; Black SJ; Johnson PJ
Equine Vet J; 2018 Jul; 50(4):537-543. PubMed ID: 29112289
[TBL] [Abstract][Full Text] [Related]
35. On the capacity of the rat intestine to excrete lithium ions at therapeutic and toxic plasma lithium concentrations.
Erbil Y; Eroglu L; Forth W; Schmolke G; Elsenhans B; Schümann K
J Trace Elem Electrolytes Health Dis; 1993 Jun; 7(2):95-9. PubMed ID: 8219751
[TBL] [Abstract][Full Text] [Related]
36. Mechanism of the tissue distribution and biliary excretion of the cyclic peptide octreotide.
Yamada T; Niinuma K; Lemaire M; Terasaki T; Sugiyama Y
J Pharmacol Exp Ther; 1996 Dec; 279(3):1357-64. PubMed ID: 8968360
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics and biliary excretion of mitoxantrone in rats.
Yang X; Morris ME
J Pharm Sci; 2010 May; 99(5):2502-10. PubMed ID: 20013854
[TBL] [Abstract][Full Text] [Related]
38. Alteration in the biliary and urinary excretion of acetaminophen metabolites by nephrotoxicants in rats.
Seo KW; Choung SY; Park KS; Kim HJ
Res Commun Mol Pathol Pharmacol; 1997 Mar; 95(3):305-17. PubMed ID: 9144837
[TBL] [Abstract][Full Text] [Related]
39. Biliary excretion of tetrodotoxin in the cultured pufferfish Takifugu rubripes juvenile after intramuscular administration.
Matsumoto T; Kiriake A; Ishizaki S; Watabe S; Nagashima Y
Toxicon; 2015 Jan; 93():98-102. PubMed ID: 25450801
[TBL] [Abstract][Full Text] [Related]
40. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
